Episode 6: Utrecht's measure of a professor

Fintan takes us to the Netherlands, where a new method of measuring the performance of academics is about to be trialled. Will it deflate the impact factor rating system? Also: Joseph describes an investigative news story about drug companies finding loopholes in EU regulations to charge exorbitant fees to consumers, with patients of rare diseases being the most affected. Also, our hosts breathe a collective sigh of relief that today's Olympians don't have to deal with sports medicine from the Games of Antiquity.

Follow us on Twitter!
50 Ways to Say Science: @50waysscipod
Joseph Piergrossi: @JWPiergrossi
Fintan Burke: @SciFintan

Fintan's article on German research strategy: https://sciencebusiness.net/news/german-researchers-draw-demands-incoming-science-minister
Charlie Haynes' and Flora Carmichael's feature on the Fazze YouTuber scam case: https://www.bbc.com/news/blogs-trending-57928647

Sources:
Investigative reporting by Michele Catanzaro and Astrid Viciano: https://www.elperiodico.com/es/cuaderno/20210723/enfermedades-raras-negocio-farmaceuticas-precios-afectados-testimonios-11933040
https://www.acm.nl/en/publications/acm-imposes-fine-drug-manufacturer-leadiant-cdcas-excessive-price
Hedwig Fossen on "Erkennen en waarderen": https://www.volkskrant.nl/wetenschap/academici-soebatten-over-de-vraag-hoe-je-meet-dat-een-wetenschapper-goed-scoort-publicaties-of-iets-anders~bce65cfe/
Opposition to "Erkennen en waarderen": https://www.scienceguide.nl/2021/07/nieuwe-erkennen-en-waarderen-schaadt-nederlandse-wetenschap/
https://twitter.com/SciTransitYoung/status/1418497730893201409?s=20
Signatories of Hanneke Hulke's counter-petition against the opposition: https://docs.google.com/document/d/1jbRnVUZogKjk_mItTriQtotv775ucCX1LrrQ3_1JuKg/edit
https://www.germanjournalsportsmedicine.com/fileadmin/content/archiv2012/Heft_1/online/Geschichte_Arndt.pdf